Key result
Cornell voltage product yields best diagnostic accuracy for detecting LVH with ~0.76 AUROC.
Why the study?
ECG criteria for detecting LVH were largely derived from non-African populations, leaving their diagnostic performance uncertain in Black African adults with untreated hypertension.
Does established ECG-LVH criteria accurately detect echocardiographically defined LVH in Black African adults with untreated hypertension?
Cross-Sectional (n=1,125)
Yes
Does established ECG-LVH criteria accurately detect echocardiographically defined LVH in Black African adults with untreated hypertension?
Cornell voltage product-based ECG criteria offer the most reliable diagnostic performance for detecting LVH in hypertensive Black African adults, highlighting the need for population-specific validation.
Answers are grounded in this paper and cite their sources.
May support ECG screening for LVH in Black African hypertensives; extends non-African criteria but leaves open prospective validation needs.
Background: Electrocardiographic (ECG) criteria for detecting left ventricular hypertrophy (LVH) have largely been derived from non-African populations. Their diagnostic performance in Black African adults with untreated hypertension remains uncertain. Objective: To evaluate the diagnostic performance of established ECG-LVH criteria compared with echocardiographically assessed left ventricular mass index (LVMI) in Black African adults with untreated, uncomplicated hypertension enrolled in the coArtHA trial. Methods: In this subanalysis, we included 1,125 participants from rural Tanzania and Lesotho who underwent baseline 12-lead ECG and focused transthoracic echocardiography (fTTE). LVH was defined as LVMI > 95 g/m² in women, and >115 g/m² in men. Diagnostic performance of multiple ECG-LVH criteria was assessed using correlation analyses, sensitivity and specificity estimates, receiver-operating characteristic (ROC) analysis, including calculation of the area under the ROC curve (AUROC), and precision-recall curves (PRC). Among evaluated criteria, Cornell voltage product-based measures demonstrated the most consistent diagnostic performance across evaluated metrics, with an AUROC of approximately 0.76. Using established cut-off values, this criterion yielded a sensitivity of 64% and a specificity of 80%, whereas voltage-only criteria, including Multi-Ethnic Study of Atherosclerosis (MESA)- and Sokolow-Lyon-based indices, showed limited accuracy in this setting. Exploratory analyses of alternative cut-off values demonstrated the expected sensitivity-specificity trade-offs. Conclusions: In this cohort of hypertensive Black African adults, ECG criteria showed a moderate association with LVMI by echocardiography. Among established ECG criteria, Cornell voltage product-based measures demonstrated the most consistent diagnostic performance. Diagnostic characteristics were strongly influenced by cut-off selection and clinical context, underscoring the need for population-specific evaluation and external validation of ECG criteria for LVH in African settings. Trial registration: Clinicaltrials.gov NCT04129840. Registered on October 17, 2019 (https://www.clinicaltrials.gov/).
No takes yet. Share an insight, caveat, or question.
Vischer et al. (2026) conducted a cross-sectional in untreated, uncomplicated hypertension (n=1,125). Established ECG-LVH criteria (Cornell voltage product) vs. Echocardiographically assessed left ventricular mass index (LVMI) was evaluated on Diagnostic performance (AUROC) of Cornell voltage product for detecting LVH (AUROC 0.765, p=<0.001). Among established ECG criteria, Cornell voltage product-based measures demonstrated the most consistent diagnostic performance for detecting LVH, with an AUROC of approximately 0.76.
Synapse has enriched 10 related papers. Consider them for comparative context: